Association of promoter variants in the α7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia

Archives of General Psychiatry

Volumn 59, Issue 12, 2002, Pages 1085-1096

  Leonard, Sherry ^a,b   Gault, Judith ^a   Hopkins, Jan ^b   Logel, Judith ^a   Vianzon, Ruby ^a   Short, Margaret ^b   Drebing, Carla ^a   Berger, Ralph ^a   Venn, Diana ^a   Sirota, Pinkhas ^c   Zerbe, Gary ^a   Olincy, Ann ^a,b   Ross, Randal G ^a,b   Adler, Lawrence E ^a,b   Freedman, Robert ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BUNGAROTOXIN RECEPTOR; NICOTINIC RECEPTOR; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; EVOKED AUDITORY RESPONSE; GENE MUTATION; GENETIC LINKAGE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PROMOTER REGION; PSYCHOSIS; REDUCTION; SCHIZOPHRENIA; SCREENING; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS;

AUDITORY PERCEPTUAL DISORDERS; BRAIN; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 15; DNA MUTATIONAL ANALYSIS; EVOKED POTENTIALS, AUDITORY; HUMANS; LYMPHOCYTES; NEURAL INHIBITION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROMOTER REGIONS (GENETICS); RECEPTORS, NICOTINIC; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEQUENCE ANALYSIS, DNA; VARIATION (GENETICS);

EID: 0036897309     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.59.12.1085     Document Type: Article

References (72)

1. Brzustowicz LM, Hodgkinson KA, Chow EWC, Honer WG, Bassett AS. Location of a major susceptibility locus for familiar schizophrenia on chromosome 1q21-q22. Science. 2000;288:678-682.
2. Straub RE, MacLean CJ, Kendler KS. The putative schizophrenia locus on chromosome 6p: A brief overview of the linkage studies. Mol Psychiatry. 1996;1: 89-92.
3. Cao Q, Martinez M, Zhang J, Sanders AR, Badner JA, Cravchik A, Markey CJ, Beshah E, Guroff JJ, Maxwell ME, Kazuba DM, Whiten R, Goldin LR, Gershon ES, Gejman PV. Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. Genomics. 1997;43:1-8.
4. Blouin JL, Dombroski BA, Nath SK, LasseterVK, Wolyniec PS, Nestadt G, Thornquist M, Ullrich G, McGrath J, Kasch L, Lamacz M, Thomas MG, Gehrig C, Radhakrishna U, Snyder SE, Balk KG, Neufeld K, Swartz KL, DeMarchi N, Papadimitriou GN, Dikeos DG, Stefanis CN, Chakravarti A, Childs B, Pulver AE. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet. 1998; 20:70-73.
5. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B, Hampe C, Zambuto CT, Schmitt K, Meyer J, Markel P, Lee H, Harkavy-Friedman J, Kaufmann C, Cloninger CR, Tsuang MT. Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet. 1998;81:290-295.
6. Riley BP, Makoff AM, Magudi-Carter M, Jenkins TJ, Williamson R, Collier DA, Murray RM. Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. Am J Med Genet. 2000;96:196-201.
7. Stöber G, Saar K, Rüschendorf F, Meyer J, Nürnberg G, Jatzke S, Franzek E, Reis A, Lesch KP, Wienker TF, Beckmann H. Splitting schizophrenia: Periodic catatonia-susceptibility locus on chromosome 15q15. Am J Med Genet. 2000; 67:1201-1207.
8. Stassen HH, Bridler R, Hagele S, Hergersberg M, Mehmann B, Schinzel A, Weisbrod M, Scharfetter C. Schizophrenia and smoking: Evidence for a common neurobioiogical basis? Am J Med Genet. 2000;96:173-177.
9. Freedman R, Leonard S, Gault JM, Hopkins J, Cloninger CR, Kaufmann CA, Tsuang MT, Farone SV, Malaspina D, Svrakic DM, Sanders A, Gejman P. Link-age disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha 7-nicotinic acetylcholine receptor subunit gene (CHRNA7). Am J Med Genet. 2001;105:20-22.
10. Liu C-M, Hwu H-G, Lin M-W, Ou-Yang W-C, Lee SF-C, Fann CSJ, Wong S-H, Hsieh S-H. Suggestive evidence for linkage of schizophrenia to markers at chromosome 15q13-14 in Taiwanese families. Am J Med Genet. 2001;105:658-661.
11. Xu J, Pato MT, Torre CD, Medeiros H, Carvalho C, Basile VS, Bauer A, Dourado A, Valente J, Soares MJ, Macedo AA, Coelho I, Ferreira CP, Azevedo MH, Macciardi F, Kennedy JL, Pato CN. Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families. Am J Med Genet. 2001;105:669-674.
12. Tsuang DW, Skol A, Faraone SV, Bingham S, Young KA, Prabhudesai S, Haverstock SL, Mena F, Menon AS, Bisset D, Pepple J, Johnson J, Baldwin C, Weiss D, Collins J, Boehnke M, Schellenberg GD, Tsuang MT. Genetic linkage of the CHRNA7 region on chromosome 15 to schizophrenia in a large Veterans Affairs cooperative study sample. Am J Med Genet. 2001;105:662-668.
13. Gejman PV, Sanders AR, Badner JA, Cao Q, Zhang J. Linkage analysis of schizophrenia to chromosome 15. Am J Med Genet. 2001;105:789-793.
14. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G, Antonarakis S, Housman D, Kazazian HH, Meyers D, Ott J, Lamacz M, Liang KY, Hanfelt J, Ullrich G, DeMarchi N, Ramu E, McHugh PR, Adler L, Thomas M, Carpenter WT, Manshreck T, Gordon CT, Kimberland M, Babb R, Puck J, Childs B. Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on chromosome 22q12-q13. Am J Med Genet. 1994;54:36-43.
15. Baron M. Genetics of schizophrenia and the new millennium: Progress and pit. falls. Am J Hum Genet. 2001;68:299-312.
16. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA. 1997;94:587-592
17. Leonard S, Gault J, Moore T, Hopkins J, Robinson M, Olincy A, Adler LE, Cloninger CR, Kaufmann CA, Tsuang MT, Faraone SV, Malaspina D, Svrakic DM, Freedman R. Further investigation of a chromosome 15 locus in schizophrenia: Analysis of affected sibpairs from the N IMH Genetics Initiative. Am J Med Genet. 1998 81:308-312.
18. Freedman R, Leonard SS. Chromosome 15q linkage for schizophrenia in the NIMH genetics initiative families [abstract]. Schizophr Res. 2001;49:70.
19. Freedman R, Leonard S, Olincy A, Kaufmann CA, Malaspina D, Cloninger CR, Svrakic D, Faraone SV, Tsuang MT. Evidence for the multigenic inheritance of schizophrenia. Am J Med Genet. 2001;105:794-800.
20. Kaufmann CA, Suarez B, Malaspina D, Pepple J, Svrakic D, Markel PD, Meyer J, Zambuto CT, Schmitt K, Matise TC, Harkavy-Friedman JM, Hampe C, Lee H, Shore D, Wynne D, Faraone SV, Tsuang MT, Cloninger CR. NIMH genetics initiative millenium schizophrenia Consortium: Linkage analysis of African-American pedigrees. Am J Med Genet. 1998;81:282-289.
21. Elmslie FV, Rees M, Williamson MP, Kerr M, Kjeldsen MJ, Pang KA, Sundqvist A, Friis ML, Chadwick D, Richens A, Covanis A, Santos M, Arzimanoglou A, Panayiotopoulos CP, Curtis D, Whitehouse WP, Gardiner RM. Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet. 1997;6:1329-1334.
22. Edenberg HJ, Foroud T, Conneally PM, Sorbel JJ, Carr K, Crose C, Willig C, Zhao J, Miller M, Bowman E, Mayeda A, Rau NL, Smiley C, Rice JP, Goate A, Reich T, Stine OC, McMahon F, DePaulo JR, Meyers D, Detera-Wadleigh SD, Goldin LR, Gershon ES, Blehar MC, Nurnberger JI Jr. Initial genomic scan of the NIMH genetics initiative bipolar pedigrees: Chromosomes 3, 5, 15, 16, 17, and 22. Am J Med Genet. 1997;74:238-246.
23. Turecki G, Grof P, Grof E, D'Souza V, Lebuis L, Marineau C, Cavazzoni P, Duffy A, Robertson LC, Bétard C, Zvolsky P, Brewer C, Hudson TJ, Rouleau GA, Alda M. Mapping susceptibility genes for bipolar disorder: A pharmacogenetic approach based on excellent response to lithium. Mol Psychiatry. 2001;6:570-578.
24. Adler LE, Olincy A, Waldo MC, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull. 1998;24:189-202.
25. Leonard S, Adler LE, Olincy A, Breese CR, Gault J, Ross RG, Lee M, Cawthra E, Nagamoto HT, Freedman R. The role of nicotine and nicotinic receptors in psychopathology. In: Arneric SP, Brioni JD, eds. Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. New York, NY: Wiley-Liss Inc; 1998: 305-320.
26. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry. 1992;32:607-616.
27. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry. 1993;150:1856-1861.
28. Freedman R, Waldo M, Bickford-Wimer P, Nagamoto H. Elementary neuronal dysfunctions in schizophrenia. Schizophr Res. 1991;4:233-243.
29. Baker N, Adler LE, Franks RD, Waldo M, Berry S, Nagamoto H, Muckle A, Freedman R. Neurophysioiogical assessment of sensory gating in psychiatric inpatients: Comparison between schizophrenia and other diagnoses. Biol Psychiatry. 1987;22:603-617.
30. Adler LE, Pachtman E, Franks R, Pecevich M, Waldo MC, Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 1982;17:639-654.
31. Clementz BA, Geyer MA, Braff DL. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res. 1998; 30:71-80.
32. Yee CM, Nuechterlein KH, Morris SE, White PM. P50 suppression in recentonset schizophrenia: Clinical correlates and risperidone effects. J Abnorm Psychol, 1998;107:691-698.
33. Erwin RJ, Turetsky BI, Moberg P, Gur RC, Gur RE, P50 abnormalities in schizophrenia: Relationship to clinical and neuropsychological indices of attention. Schizophr Res. 1998;33:157-167.
34. Patterson JV, Jin Y, Gierczak M, Hetrick WP, Potkin S, Bunney WE, Sandman CA. Effects of temporal variability on P50 and the gating ratio in schizophrenia: A frequency domain adaptive filter single-trial analysis. Arch Gen Psychiatry. 2000;57:57-64.
35. Freedman R, Adler LE, Baker N, Waldo M, Mizner G. Candidate for inherited neurobiological dysfunction in schizophrenia. Somat Cell Mol Genet. 1987;13: 479-484.
36. Clementz BA, Geyer MA, Braff DL. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry. 1998;155: 1691-1694.
37. Waldo MC, Adler LE, Leonard S, Olincy A, Ross RG, Harris JG, Freedman R. Familial transmission of risk factors in the first-degree relatives of schizophrenic people. Biol Psychiatry. 2000;47:231-239.
38. Coon H, Plaetke R, Holik J, Hoff M, Myles-Worsley M, Waldo M, Freedman R, Byerley W. Use of a neurophysiological trait in linkage analysis of schizophrenia. Biol Psychiatry. 1993;34:277-289.
39. Luntz-Leybman V, Bickford PC, Freedman R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res. 1992;587:130-136.
40. Rollins YD, Stevens KE, Harris KR, Hall ME, Rose GM, Leonard S. Reduction in auditory gating following intracerebroventricular application of α-bungarotoxin binding site ligands and α7 antisense oligonucleotides [abstract]. Soc Neurosci Abstr. 1993;19:837.
41. Stevens KE, Freedman R, Collins AC, Hall M, Leonard S, Marks JM, Rose GM. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and α-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology. 1996;15:152-162.
42. Stevens KE, Kem WR, Mahnir VM, Freedman R. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology. 1998;136:320-327.
43. Freedman R, Hall M, Adler LE, Leonard S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry. 1995;38:22-33.
44. Court J, Spurden D, Lloyd S, McKeith I, Ballard C, Cairns N, Kerwin R, Perry R, Perry E. Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: Alpha-bungarotoxin and nicotine binding in the thalamus. J Neurochem. 1999;73:1590-1597.
45. Guan ZZ, Zhang X, Blennow K, Nordberg A. Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain. Neuroreport. 1999;10:1779-1782.
46. Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J, Moore T, Jacobs S, Meriwether J, Choi MJ, Kim EJ, Walton K, Buiting K, Davis A, Breese CR, Freedman R, Leonard S. Genomic organization and partial duplication of the human α7 neuronal nicotinic acetylcholine receptor gene. Genomics. 1998;52:173-185.
47. Quandt K, Frech K, Karas H, Wingender E, Werner T. Matlnd and Matlnspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 1995;23:4878-4884.
48. Carrasco-Serrano C, Campos-Caro A, Viniegra S, Ballesta JJ, Criado M. GC- and E-box motifs as regulatory elements in the proximal promoter region of the neuronal nicotinic receptor alpha7 subunit gene. J Biol Chem. 1998;273:20021-20028.
49. Leonard S, Logel J, Luthman D, Casanova M, Kirch D, Freedman R. Biological stability of mRNA isolated from human postmortem brain collections. Biol Psychiatry. 1993;33:456-466.
50. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual. 3rd Ed. Cold Spring Harbor, NY: Cold Spring Harbor Press; 2001.
51. First MB, Gibbon M, Spitzer RL, Williams JBW. Structured Clinical Interview for Axis I DSM-IV Disorders - Non-Patient Edition (SCID-I/NP, Version 2.0). New York: Biometrics Research Dept, New York State Psychiatric Institute; 1996.
52. Endicott J, Andreasen NC, Spitzer RL. Family History-Research Diagnostic Criteria. 3rd Ed. New York: Research Assessment and Training Unit, New York State Psychiatric Institute; 1978.
53. Flora A, Schulz R, Benfante R, Battaglioli E, Terzano S, Clementi F, Fornasari D. Transcriptional regulation of the human alpha 5 nicotinic receptor subunit gene in neuronal and non-neuronal tissues. Eur J Pharmacol. 2000;393:85-95.
54. Couturier S, Bertrand D, Matter J-M, Hernandez M-C, Bertrand S, Millar N, Valera S, Barkas T, Ballivet M. A neuronal nicotinic acetylcholine receptor subunit α7 is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX. Neuron. 1990;5:847-856.
55. Lander ES, Schork NJ. Genetic dissection of complex traits. Science. 1994;265: 2037-2048.
56. Gershon ES. Bipolar illness and schizophrenia as oligogenic diseases: Implications for the future. Biol Psychiatry. 2000;47:240-244.
57. Venables P. Input dysfunction in schizophrenia. In: Maher BA, ed. Progress in Experimental Personality Research. New York, NY: Academic Press; 1964:1-47.
58. Freedman R, Adler LE, Leonard S. Alternative phenotypes for the complex genetics of schizophrenia. Biol Psychiatry. 1999;45:551-558.
59. Freedman R, Adler LE, Baker N, Waldo M, Mizner G. Candidate for inherited neurobiological dysfunction in schizophrenia. Somat Cell Mol Genet 1987;13:479-484.
60. Holzman PS. Eye movement dysfunctions and psychosis. Int Rev Neurobiol. 1985; 27:179-205.
61. Holzman PS, Kringlen E, Matthysse S, Flanagan SD, Lipton RB, Cramer G, Levin S, Lange K, Levy DL. A single dominant gene can account for eye tracking dysfunctions and schizophrenia in offspring of discordant twins. Arch Gen Psychiatry. 1988;45:641-647.
62. Leonard S, Breese C, Adams C, Benhammou K, Gault J, Stevens K, Lee M, Adler L, Olincy A, Ross R, Freedman R. Smoking and schizophrenia: Abnormal nicotinic receptor expression. Eur J Pharmacol. 2000;393:237-242.
63. Leonard S, Gault J, Adams C, Breese CR, Rollins Y, Adler LE, Olincy A, Freedman R. Nicotinic receptors, smoking and schizophrenia. Restor Neurol Neurosci. 1998;12:195-201.
64. Theuns J, Del Favero J, Dermaut B, van Duijn CM, Backhovens H, Van den Broeck M, Serneels S, Corsmit E, van Broeckhoven C, Cruts M. Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression. Hum Mol Genet. 2000;9:325-331.
65. Knight JC, Udalova I, Hill AVS, Greenwood BM, Peshu N, Marsh K, Kwiatkowski D. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet. 1999;22:145-150.
66. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet. 2001;68:1428-1436.
67. Melnikova IN, Yang Y, Gardner PD. Interactions between regulatory proteins that bind to the nicotinic receptor beta 4 subunit gene promoter. Eur J Pharmacol. 2000;393:75-83.
68. Croft RJ, Lee A, Bertolot J, Gruzelier JH. Associations of P50 suppression and desensitization with perceptual and cognitive features of "unreality" in schizotypy. Biol Psychiatry. 2001;50:441-446.
69. Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL. Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: Evidence of inhibitory deficits. Am J Psychiatry. 2000;157:1660-1668.
70. Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan A, Stengard J, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet. 1998;63:595-612.
71. 108-158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98:6917-6922.
72. Horikawa Y, Oda N, Cox NJ, Li XQ, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PEH, Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla, S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze T, Baler LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000;26:163-175.